Navigation Links
GenSpera to Present at Rodman & Renshaw 16th Annual Global Investment Conference
Date:8/14/2014

SAN ANTONIO, Aug. 14, 2014 /PRNewswire/ -- GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, announces it will be presenting at the Rodman & Renshaw 16th Annual Global Investment Conference. The conference will be held September 8-10, 2014 at the New York Palace Hotel in New York.

The conference is attended by public companies, institutional investors, sophisticated private investors and industry executives.

GenSpera will be presenting at 12:05 pm Tuesday, September 9th. The Company will discuss the significance of the recently announced HCC clinical trial update for G-202, its lead drug candidate, as well as provide a corporate overview. The company has released interim results from the Phase Ib and ongoing Phase II study in hepatocellular carcinoma (HCC) patients who had previously progressed on, or who were intolerant of sorafenib ( Nexavar®, a drug co-developed and co-marketed by Bayer and Onyx Pharmaceuticals, an Amgen subsidiary).  Impressively, 80% of patients treated with G-202 had stable disease (no tumor growth) at two months and 50% of patients exhibited stable disease at 4 months on study. In addition, imaging analysis demonstrated impressive blockade of tumor blood flow in the single patient evaluated by this method to date.

Hepatocellular carcinoma (HCC) is currently the sixth most common malignancy in the world and the third leading cause of cancer-related mortality worldwide.

Craig Dionne, PhD, GenSpera's CEO said of the pending conference," I am excited to share the recent data and results for G-202 and its efficacy and safety analyses on patients to date. G-202 has potential to treat multiple cancers including prostate cancer and glioblastoma but our primary focus is currently hepatocellular carcinoma (HCC). The liver cancer data we recently presented at APPLE and other sc
'/>"/>

SOURCE GenSpera, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. GenSpera Presents G-202 HCC Clinical Trial Update at 5th Asia-Pacific Primary Liver Cancer Expert Meeting
2. Kareg Corporation Initiates Coverage on GenSpera with a Speculative Buy Recommendation
3. Aventura Client Presents Enhancing Emergency Department Documentation Efficiency at Optum Client Forum 2014
4. Lpath to Present at 34th Annual Canaccord Genuity Growth Conference
5. Genomic Health to Present at the Canaccord Genuity 34th Annual Growth Conference
6. Lexicon To Present At The 2014 Wedbush Life Sciences Management Access Conference
7. Omeros to Present at the Wedbush PacGrow 2014 Life Sciences Management Access Conference
8. Guardant Health to Present at the WedBush 2014 Life Sciences Management Access Conference
9. Mast Therapeutics To Present At The Canaccord Genuity 34th Annual Growth Conference On August 14th
10. STAAR Surgical To Present At Wedbush And Canaccord Investor Conferences
11. KemPharm, Inc. to Present at the Canaccord Genuity 34th Annual Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 2015   MultiVir Inc. ("MultiVir"), a clinical-stage ... candidates for the treatment of multiple oncological indications, today ... on Form S-1 with the U.S. Securities and Exchange ... of shares of its common stock. The number of ... the proposed offering have not yet been determined. MultiVir ...
(Date:3/30/2015)... Sorrento Therapeutics, Inc. (Nasdaq: SRNE ) ... to the position of Executive Vice President & ... be responsible for all legal, compliance and intellectual property ... BioDelivery Sciences International, Inc., where he was Senior Vice ... management that led that company to over a six ...
(Date:3/30/2015)... 30, 2015 Alere Inc. (NYSE: ALR ... following statement today in support of President Barack ... "As the global leader in rapid ... Obama for establishing a National Action Plan with ... threat of antibiotic resistance. We look forward to continuing ...
Breaking Medicine Technology:MultiVir Files Registration Statement for Proposed Initial Public Offering 2Sorrento Announces Appointment Of George Ng As EVP & Chief Legal Officer 2Sorrento Announces Appointment Of George Ng As EVP & Chief Legal Officer 3Alere Applauds President's National Action Plan to Combat Antibiotic-Resistant Bacteria 2
... Poster Presented at ASCO Annual Meeting -, ... May 31 /PRNewswire-FirstCall/,-- Poniard Pharmaceuticals, Inc. (Nasdaq: ... oncology, today presented preliminary safety and,efficacy data ... of picoplatin in,combination with docetaxel and prednisone, ...
... ... Other Organs-, -All Patients Surpassed Expected Median Survival Time at Lowest Planned ... ... PPHM ) today reported that clinical,researchers from the Abramson Cancer Center of the University ...
Cached Medicine Technology:Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer 2Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer 3Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer 4Data To Be Presented at ASCO Supports Potential of Peregrine's Cotara(R) for the Treatment of Brain Cancer 2Data To Be Presented at ASCO Supports Potential of Peregrine's Cotara(R) for the Treatment of Brain Cancer 3Data To Be Presented at ASCO Supports Potential of Peregrine's Cotara(R) for the Treatment of Brain Cancer 4Data To Be Presented at ASCO Supports Potential of Peregrine's Cotara(R) for the Treatment of Brain Cancer 5
(Date:3/30/2015)... Rosa, CA (PRWEB) March 30, 2015 KIND ... of LED grow light products in 2015. The excellent value ... enabled them to take the pole position in the race ... leading feature of the KIND LED suite of grow lights ... the most plant-friendly Photosynthetic Active Radiation (PAR) wavelengths that plants ...
(Date:3/30/2015)... Health Fitness Revolution, founded by renowned fitness expert and ... has created a new list of the Top 13 ... fittest leaders in terms of physical fitness, health and wellness. ... kind to detail the health and fitness habits of reigning ... profiled on the list are Israel’s Benjamin Netanyahu, Russia’s Vladimir ...
(Date:3/30/2015)... Lake City, Itah (PRWEB) March 30, 2015 ... health insurance reimbursement for small businesses, announced its ... You?" is available on webcast. This discussion was ... , According to Zane Benefits, there is ... by small businesses. Instead of selecting a group ...
(Date:3/30/2015)... 30, 2015 A new Zofran lawsuit ... Superior Court on behalf of a child who was ... his mother was prescribed the anti-nausea medication during the ... filing in Alameda Superior Court, the baby’s mother was ... she experienced in the early months of her pregnancy. ...
(Date:3/30/2015)... “ iCareTech ” was featured on NewsWatch ... look at the latest and coolest technology products and services ... technology expert, conducted the review and shared with viewers how ... the medical and health fields. , Wearable technology has been ... past couple of years. Well, at CES, NewsWatch TV came ...
Breaking Medicine News(10 mins):Health News:Best LED Grow Lights of 2015 Are Being Led By KIND LED 2Health News:The Top 13 Fittest Heads of State: Why Putin Might Be No. 1 in Health and Fitness 2Health News:Zane Benefits New Webinar Premium Reimbursement Webinar Now Available On-Demand 2Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 2Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 3Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 4Health News:World’s First Medical Intelligent Band was Featured on NewsWatch Television on January 30, 2015 2
... , , WALTHAM, ... (MRG), the global authority on medical technology market intelligence, ... cuts to reimbursement for hospital-acquired infections are resulting in ... central venous catheters (CVCs). MRG,s US Markets for ...
... CROFTON, Md., July 22 Dr. Robert Graw announced Nighttime Care ... the Muddy Branch Square Shopping Center at 882 Muddy Branch Road, ... year to serve children and adults when residents do not have ... and prescription services. , , "This ...
... , , REDWOOD ... announced positive results from its first Phase 2 clinical ... of its ARX-01 Sufentanil NanoTab(TM) PCA System for management ... during hospitalization. Patients reliably self-administered sufentanil NanoTabs repeatedly over ...
... , , Increased Volume Drives Revenue Growth Despite ... Improved Gross Margin Percent , Earnings Rise 20% to $1.06 (reported); ... Reported EPS Guidance ... Pro forma non-GAAP EPS Guidance Range Raised to $4.20 to $4.30 per share , ...
... ... a competitive advantage Fastrack has introduced new functionality to its, Enterprise System that will ... features designed to help manage critical business processes that will improve productivity and reduce ... ...
... ... announced a successful demonstration of five community-based health information exchange (HIE) projects in ... information to improve patient care. , ... San Francisco, CA (PRWEB) July 20, 2009 -- ...
Cached Medicine News:Health News:Following CMS Cuts to Reimbursement for Medical Errors, New Devices Aimed at Reducing Nosocomial Infections Emerge 2Health News:Following CMS Cuts to Reimbursement for Medical Errors, New Devices Aimed at Reducing Nosocomial Infections Emerge 3Health News:Nighttime Care Centers Announces New Urgent Care Medical Clinic in Montgomery County, Maryland 2Health News:AcelRx Announces Perfect Performance of Handheld Component of ARX-01 Sufentanil NanoTab PCA System in a Phase 2 Study 2Health News:AcelRx Announces Perfect Performance of Handheld Component of ARX-01 Sufentanil NanoTab PCA System in a Phase 2 Study 3Health News:Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance 2Health News:Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance 3Health News:Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance 4Health News:Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance 5Health News:Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance 6Health News:Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance 7Health News:Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance 8Health News:Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance 9Health News:Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance 10Health News:Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance 11Health News:Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance 12Health News:Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance 13Health News:Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance 14Health News:Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance 15Health News:Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance 16Health News:Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance 17Health News:Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance 18Health News:Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance 19Health News:Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance 20Health News:Fastrack Automates Workflow For Homecare Providers 2Health News:Fastrack Automates Workflow For Homecare Providers 3Health News:CAeHC Demonstrates NHIN-enabled Gateways Among Five California Health Information Exchanges 2Health News:CAeHC Demonstrates NHIN-enabled Gateways Among Five California Health Information Exchanges 3Health News:CAeHC Demonstrates NHIN-enabled Gateways Among Five California Health Information Exchanges 4Health News:CAeHC Demonstrates NHIN-enabled Gateways Among Five California Health Information Exchanges 5Health News:CAeHC Demonstrates NHIN-enabled Gateways Among Five California Health Information Exchanges 6
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: